Celltrion's anti-COVID-19 monoclonal antibody treatment candidate looks promising
Therapeutics | News | 0 Comment | 09 Nov, 2020
Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...Read more
Singapore's single-cell precision medicine company 'Proteona' wins Start-up award
Therapeutics | News | 0 Comment | 09 Nov, 2020
Singapore single cell precision medicine company Proteona has been selected as one of the ten winners of Falling Walls B...Read more
Taiwan accelerates pace of gene-editing technologies into clinical settings
Therapeutics | News | 0 Comment | 06 Nov, 2020
In research endeavors to find a cure for many diseases, CRISPR/Cas9 has becoming a precise tool to modify the DNA in mic...Read more
Australia designs model to link heart disease with T2D
Therapeutics | News | 1 Comment | 04 Nov, 2020
Researchers from Australia's University of Sydney’s School of Project Management within the Faculty...Read more
Avatamed, Macrogen focus on personalized precision medicine services in cancer treatment
Therapeutics | News | 0 Comment | 04 Nov, 2020
AVATAMED, a precision medicine service company based in Singapore, represented by CEO Hong Boon Toh, has enter...Read more
SK Biopharma and LifeSci Venture Partners to push open innovation
Therapeutics | News | 0 Comment | 04 Nov, 2020
SK Biopharmaceuticals, a global innovative pharmaceutical company based in South Korea, has announced that the company h...Read more
PerkinElmer to acquire Horizon Discovery for $383M
Therapeutics | News | 0 Comment | 02 Nov, 2020
PerkinElmer, Inc. and Horizon Discovery Group plc have announced that they have reached an agreement on t...Read more
Ocumension strengthens pipeline for posterior segment eye diseases in China
Therapeutics | News | 0 Comment | 30 Oct, 2020
Hong Kong's Ocumension Therapeutics announced that the Company has entered into a collaboration and exclusive ...Read more
Singapore develops new gelatin microcarrier for cell production
Therapeutics | News | 0 Comment | 29 Oct, 2020
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise i...Read more
Samsung Biologics partners with Dinona for potential COVID-19 treatment
Therapeutics | News | 0 Comment | 21 Oct, 2020
Samsung Biologics has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities t...Read more
Axis Therapeutics, PharmaEssentia focus on providing TCR-T cell therapy in Taiwan
Therapeutics | News | 0 Comment | 15 Oct, 2020
Axis Therapeutics Limited based in the US and Hong Kong, a joint venture between Athenex, Inc. and Xiangxue Life Science...Read more
Merck launches VirusExpress platform to push cell and gene therapies
Therapeutics | News | 0 Comment | 14 Oct, 2020
Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentivir...Read more
Antengene partners with WuXi Biologics for innovative oncology medicines
Therapeutics | News | 0 Comment | 14 Oct, 2020
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...Read more
Korean startup Kanaph Therapeutics closes $21M Series B funding
Therapeutics | News | 0 Comment | 14 Oct, 2020
Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecul...Read more
Korea develops method to detect COVID-19 RNAs in 30 min
Therapeutics | News | 0 Comment | 12 Oct, 2020
A joint Korean research team comprised of Professor Jeong Wook Lee and Ph.D. candidate Chang Ha Woo and Professor Gyoo Y...Read more
Bone Therapeutics introduces bone cell therapy platform in China & Southeast Asia
Therapeutics | News | 0 Comment | 12 Oct, 2020
Bone Therapeutics, the cell therapy company based in Belgium addressing unmet medical needs in orthopedics and other dis...Read more
Australia leads project on pain research
Therapeutics | News | 0 Comment | 12 Oct, 2020
Why back pain persists in some cases but not others will be the focus of an international study, which has received more...Read more
Gilead to present antiretroviral therapies at virtual APACC 2020 conference
Therapeutics | News | 0 Comment | 09 Oct, 2020
Gilead Sciences, Inc. on 9 Oct 2020 announced that four abstracts have been selected for poster presentations at th...Read more